SCHEMBL22954101

SCHEMBL22954101

c1ccc(-c2oc3cccc(-c4c5ccccc5c(-c5ccccc5)c5ccccc45)c3c2-c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 1/20 0.43
▸ PLA2G4A P47712 1/20 0.43
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ ALOX15 P16050 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ DDR2 Q16832 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ CALM1 P0DP23 1/20 0.41
▸ AR P10275 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29598588 1.00 PLA2G2A (0.43) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL12623253 0.98 PLA2G2A (0.43) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL12623241 0.90 ENPP3 (0.41) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL12623218 0.88 PLA2G2A (0.41) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL12623222 0.87 PLA2G2A (0.40) PLA2G2APLA2G4AMEN1KMT2AABCG2
SCHEMBL28319788 0.86 MEN1 (0.44) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL25575882 0.86 CA1 (0.42) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL27331571 0.85 PLA2G2A (0.43) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL27360590 0.84 PLA2G2A (0.42) PLA2G2APLA2G4AMEN1KMT2ALMNA
SCHEMBL20109957 0.83 CA1 (0.40) MEN1KMT2AKDM4ETP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220162222-A1 ELECTROACTIVE COMPOUNDS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2022-05-26 — — US disclosed
US-20220162222-A1 ELECTROACTIVE COMPOUNDS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2022-05-26 — — US disclosed
CN-114514225-A Electroactive compounds 杜邦电子公司 2022-05-17 — — CN disclosed
WO-2021021840-A1 ELECTROACTIVE COMPOUNDS DUPONT ELECTRONICS, INC. (US) 2021-02-04 — — WO disclosed
WO-2021021840-A1 ELECTROACTIVE COMPOUNDS DUPONT ELECTRONICS, INC. (US) 2021-02-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162222-A1 ELECTROACTIVE COMPOUNDS KCNQ1, CYP1A1, AHR PLA2G2A 2217/4885PLA2G4A 2988/4885MEN1 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback